You limited your search to:

 Country: United States
 Collection: Congressional Research Service Reports
Medicare: Prescription Drug Proposals

Medicare: Prescription Drug Proposals

Date: June 8, 2000
Creator: O'Sullivan, Jennifer
Description: This report provides an overview of the President’s plan and the legislation introduced to date in the 106th Congress. It
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation

Medicare: Beneficiary Cost-Sharing Under Prescription Drug Legislation

Date: July 25, 2003
Creator: Peterson, Chris L
Description: This report provides an analysis of how the cost-sharing and premium provisions under the Prescription Drug and Medicare Improvement Act of 2003 (S. 1) and the Medicare Prescription Drug and Modernization Act of 2003 (H bill would affect the amount that a beneficiary would pay annually for prescription drugs.
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Date: June 17, 2003
Creator: Peterson, Chris L
Description: This report examines these proposals as well as the “Medicare Rx Drug Benefit and Discount Act of 2003,” which was introduced by Representative Charles Rangel, the ranking member of the House Ways and Means Committee. Specifically, this report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs.
Contributing Partner: UNT Libraries Government Documents Department
Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Medicare: Beneficiary Cost-Sharing Under Proposed Prescription Drug Benefits

Date: June 26, 2003
Creator: Peterson, Chris L
Description: This report provides background on how the cost-sharing and premium provisions under each bill would affect the amount that a beneficiary pays annually for prescription drugs. In addition, this report gives examples of how annual cost-sharing would differ for beneficiaries with various levels of total prescription drug spending in 2006 under the plans.
Contributing Partner: UNT Libraries Government Documents Department
Medicare Prescription Drug and Reform Legislation

Medicare Prescription Drug and Reform Legislation

Date: June 19, 2003
Creator: O'Sullivan, Jennifer; Chaikind, Hinda Ripps; Tilson, Sibyl L; Boulanger, Jennifer & Morgan, Paulette C
Description: This report describes the major features of S. 1, as ordered reported, and the measure to be considered by the House Ways and Means Committee, H.R. 2473, as ordered reported.
Contributing Partner: UNT Libraries Government Documents Department
Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House

Medicare Prescription Drug Provisions of S.1, as Passed by the Senate, and H.R. 1, as Passed by the House

Date: July 11, 2003
Creator: O'Sullivan, Jennifer
Description: This report discusses differences in the specifics of the prescription drug provisions in S. 1 and H.R. 1 and provides a side-by-side comparison of the Title I provisions of both bills.
Contributing Partner: UNT Libraries Government Documents Department
Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Federal R&D, Drug Discovery, and Pricing: Insights from the NIH-University-Industry Relationship

Date: June 19, 2000
Creator: Schacht, Wendy H
Description: Interest in methods to provide drugs at lower cost, particularly for the elderly, has rekindled discussion over the role the federal government plays in facilitating the creation of new pharmaceuticals for the marketplace. This report explores the issue of whether or not the substantial federal investment in health-related research and development (R&D) entitles the public to commensurate consideration in prices charged for any resulting drugs. It is intended to provide the reader with an understanding of the rationale for government support of R&D and subsequent efforts to facilitate private sector commercialization of new technologies generated from such work. Concerns surrounding innovation in pharmaceuticals and biotechnology are discussed within the broader context of the federal role in facilitating technological progress.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: September 10, 2001
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: October 3, 2002
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: January 3, 2003
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: June 11, 2003
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Medical Records Privacy: Questions and Answers on the HIPAA Final Rule

Date: March 10, 2004
Creator: Redhead, C. Stephen
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
HIV/AIDS International Programs: Appropriations, FY2003-FY2006

HIV/AIDS International Programs: Appropriations, FY2003-FY2006

Date: August 24, 2005
Creator: Copson, Raymond W
Description: This report discusses the funding the of international programs to fight HIV/AIDS, tuberculosis, and malaria.
Contributing Partner: UNT Libraries Government Documents Department
Prescription Drug Coverage Under Medicaid

Prescription Drug Coverage Under Medicaid

Date: March 12, 2004
Creator: Hearne, Jean & Grady, April
Description: Medicaid is a joint federal-state entitlement program that pays for medical services on behalf of certain groups of low-income persons. It is the third largest social program in the federal budget, exceeded only by Social Security and Medicare and is typically the second largest spending item for states. This report discusses prescription drug policies under the program.
Contributing Partner: UNT Libraries Government Documents Department
Hurricane Katrina and Veterans

Hurricane Katrina and Veterans

Date: September 23, 2005
Creator: Panangala, Sidath Viranga
Description: This report provides a brief overview of steps currently taken by Department of Veterans Affairs (VA) and Congress to address the needs of veterans in the affected areas.
Contributing Partner: UNT Libraries Government Documents Department
Medicaid and SCHIP: The President's FY2006 Budget Proposals

Medicaid and SCHIP: The President's FY2006 Budget Proposals

Date: June 9, 2005
Creator: Grady, April; Hearne, Jean P; Herz, Elicia J; Scott, Christine; Stone-Axelrad, Julie & Tritz, Karen
Description: This report describes the proposal and provides an estimate of the cost or savings based on publicly available information. The report provides a brief background for the proposal and provides a listing of current Congressional Research Service (CRS) reports related to the proposal.
Contributing Partner: UNT Libraries Government Documents Department
The Global Fund and PEPFAR in U.S. International AIDS Policy

The Global Fund and PEPFAR in U.S. International AIDS Policy

Date: November 3, 2005
Creator: Copson, Raymond W.
Description: The international HIV/AIDS pandemic continues to deepen. According to UNAIDS, the Joint United Nations Program on HIV/AIDS, an estimated 39.4 million people were living with HIV in 2004, including 4.9 million who were newly infected during the year. This report discusses the President’s Emergency Plan for AIDS Relief (PEPFAR), which includes bilateral programs and contributions to the multilateral Global Fund for AIDS, Tuberculosis, and Malaria.
Contributing Partner: UNT Libraries Government Documents Department
Influenza Antiviral Drugs and Patent Law Issues

Influenza Antiviral Drugs and Patent Law Issues

Date: November 18, 2005
Creator: Yeh, Brian T.
Description: This report identifies and analyzes the patent law aspects of the current avian influenza drug situation. First, the report explains the role that patent rights have played in affecting the availability of Tamiflu. Second, the report examines options for increasing the drug’s production, including the possibility of governments abrogating Roche’s patent rights by issuing compulsory licenses to other drug companies to manufacture generic versions of Tamiflu without Roche’s consent.
Contributing Partner: UNT Libraries Government Documents Department
HIV/AIDS International Programs: Appropriations, FY2003-FY2006

HIV/AIDS International Programs: Appropriations, FY2003-FY2006

Date: January 3, 2006
Creator: Salaam-Blyther, Tiaji
Description: This report briefly discusses appropriations for international HIV/AIDS programs. FY2006 Appropriations for Foreign Operations (P.L. 109-102), Labor/HHS/Education (H.Rept. 109-300), Defense, and Agriculture (P.L. 109-97) provide more than $3.4 billion for international HIV/AIDS, tuberculosis (TB), and malaria initiatives. The largest portion of the funds is provided through P.L. 109-102, which directs more than $2.8 billion to fighting the three diseases.
Contributing Partner: UNT Libraries Government Documents Department
FDA Regulation of Tobacco Products: A Policy and Legal Analysis

FDA Regulation of Tobacco Products: A Policy and Legal Analysis

Date: December 3, 2004
Creator: Redhead, C. Stephen & Feder, Jody
Description: This report examines the legislative debate over giving FDA the authority to regulate tobacco products and provides some analysis of S. 2461/H.R. 4433. It begins with an overview of the FDA’s 1996 tobacco rule that includes a summary of the agency’s arguments for asserting jurisdiction over tobacco products. That is followed by an analysis of the U.S. Supreme Court decision in FDA v. Brown & Williamson, which overturned the FDA tobacco rule. The report then reviews the 1997 proposed national tobacco settlement, which would have codified the FDA rule and given the agency explicit authority to regulate tobacco products as medical devices. It includes a discussion of the FDA provisions in the McCain tobacco bill, which was introduced and debated in the 105th Congress in an attempt to implement the proposed settlement. The final section of the report summarizes the provisions in S. 2461/H.R. 4433 and discusses some of the key issues, including preemption and the regulation of reduced-risk products.
Contributing Partner: UNT Libraries Government Documents Department
Federal Funding for Unauthorized Aliens' Emergency Medical Expenses

Federal Funding for Unauthorized Aliens' Emergency Medical Expenses

Date: October 18, 2004
Creator: Siskin, Alison
Description: This report discusses the amount of money spent, as well as the amount of federal funds available to provide emergency medical care to unauthorized (illegal) aliens in the United States. It is extremely difficult to ascertain the amount of money spent for emergency medical care for unauthorized aliens since most hospitals do not ask patients their immigration status. Additionally, prior to the passage of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (P.L. 108-173) on December 8, 2003 there were no federal funds available for the specific purpose of reimbursing hospitals or states for emergency medical care provided to unauthorized aliens (undocumented immigrants).
Contributing Partner: UNT Libraries Government Documents Department
Medical Marijuana: Review and Analysis of Federal and State Policies

Medical Marijuana: Review and Analysis of Federal and State Policies

Date: December 29, 2005
Creator: Eddy, Mark
Description: This report discusses the issue facing Congress on whether to continue to support the executive branch’s prosecution of medical marijuana patients and their providers, in accordance with marijuana’s status as a Schedule I drug under the Controlled Substances Act, or whether to relax federal marijuana prohibition enough to permit the medical use of botanical cannabis products by seriously ill persons, especially in states that have created medical marijuana programs under state law.
Contributing Partner: UNT Libraries Government Documents Department
Hospital Cost Containment

Hospital Cost Containment

Date: January 10, 1983
Creator: Lundy, Janet Pernice
Description: This report provides an overview of the dimensions of the problem of rising expenditures for hospital care, the reasons for rising hospital costs, general information on methods of controlling hospital costs and specific programs which have been developed, and some of the issues involved.
Contributing Partner: UNT Libraries Government Documents Department
Heroin: Legalization for Medical Use

Heroin: Legalization for Medical Use

Date: March 14, 1984
Creator: Blanchard, Randall, IV
Description: This report discusses the limited legalization of diacetylmorphine (heroin) for use in the medical treatment of intractable pain. The report attempts to present pros and cons on the issue as well as information on pending legislation. The report also provides a comparison of heroin's analgesic qualities to those of currently available and equivalent pharmaceutical alternatives.
Contributing Partner: UNT Libraries Government Documents Department
FIRST PREV 1 2 3 4 5 NEXT LAST